DNA damage responses in cancer stem cells: Implications for cancer therapeutic strategies

World Journal of Biological Chemistry
Qi-En Wang

Abstract

The identification of cancer stem cells (CSCs) that are responsible for tumor initiation, growth, metastasis, and therapeutic resistance might lead to a new thinking on cancer treatments. Similar to stem cells, CSCs also display high resistance to radiotherapy and chemotherapy with genotoxic agents. Thus, conventional therapy may shrink the tumor volume but cannot eliminate cancer. Eradiation of CSCs represents a novel therapeutic strategy. CSCs possess a highly efficient DNA damage response (DDR) system, which is considered as a contributor to the resistance of these cells from exposures to DNA damaging agents. Targeting of enhanced DDR in CSCs is thus proposed to facilitate the eradication of CSCs by conventional therapeutics. To achieve this aim, a better understanding of the cellular responses to DNA damage in CSCs is needed. In addition to the protein kinases and enzymes that are involved in DDR, other processes that affect the DDR including chromatin remodeling should also be explored.

References

Jan 1, 1995·Cancer Chemotherapy and Pharmacology·A JohnssonE Cavallin-Stahl
Feb 10, 1995·The Journal of Biological Chemistry·D MuA Sancar
Feb 27, 2001·FEBS Letters·J Bartek, J Lukas
Jun 19, 2001·Mutation Research·M Kartalou, J M Essigmann
Aug 21, 2001·Molecular Cell·M VolkerL H Mullenders
Oct 1, 2003·The EMBO Journal·Thilo RiedlJean-Marc Egly
Apr 2, 2004·Nature Reviews. Cancer·Stanton L Gerson
Jul 27, 2004·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Jean-Christophe AméGilbert de Murcia
Mar 15, 2006·Nature Cell Biology·Tony T HuangAlan D D'Andrea
Aug 10, 2006·Annual Review of Genetics·Claire Wyman, Roland Kanaar
Sep 26, 2007·The Journal of Cell Biology·Matilde MurgaOscar Fernandez-Capetillo
Sep 27, 2007·Journal of Cellular Physiology·Marta SimonattoPier Lorenzo Puri
Feb 8, 2008·Nature Reviews. Cancer·Thomas HelledayRicky A Sharma
May 9, 2008·Cell Stem Cell·Sol EfroniEran Meshorer
Mar 12, 2009·Molecular Cancer Research : MCR·Monica RopoloGuido Frosina
Aug 13, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amy M McCordPhilip J Tofilon
Oct 20, 2009·European Journal of Pharmacology·Zbigniew DarzynkiewiczDonald Wlodkowic
Jul 14, 2010·Cell Stem Cell·Mary MohrinEmmanuelle Passegué
Nov 12, 2010·Proceedings of the National Academy of Sciences of the United States of America·Kun XieGraham C Walker
Nov 26, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Davide SciuscioMonika E Hegi
Dec 24, 2010·Nature Reviews. Molecular Cell Biology·Alexandre Gaspar-MaiaMiguel Ramalho-Santos
Jan 27, 2011·Cancer Research·Tijana BorovskiJan Paul Medema
Feb 10, 2011·Nature Reviews. Molecular Cell Biology·Pankaj K MandalDerrick J Rossi
Apr 1, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jocelyn M StewartLaurie E Ailles
Jun 28, 2011·Nature Reviews. Cancer·Andrew J Deans, Stephen C West
Sep 14, 2011·Annual Review of Genetics·Lorraine S Symington, Jean Gautier
Nov 26, 2011·Cell Death and Differentiation·M BartucciR De Maria
Jan 20, 2012·Nature·Christopher J Lord, Alan Ashworth
Feb 24, 2012·Nature Reviews. Molecular Cell Biology·Julian E SaleRoger Woodgate
Mar 24, 2012·Cancer Cell·Jeffrey A MageeSean J Morrison
Jun 20, 2012·Journal of Cellular Biochemistry·Yulin ChenQimin Zhan

❮ Previous
Next ❯

Citations

Jul 16, 2016·Stem Cells International·Wanyin ChenMaria Zeniou
Nov 9, 2016·Critical Reviews in Oncology/hematology·Miriam López-GómezBruno Sainz
Sep 15, 2016·International Journal of Radiation Biology·Javed MahmoodZeljko Vujaskovic
Jan 20, 2017·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·A L OeiJ Crezee
Jun 8, 2017·Genes·Alpana KumariDaitoku Sakamuro
Jun 29, 2017·Chemistry : a European Journal·Chunxin LuKogularamanan Suntharalingam
Oct 5, 2018·International Journal of Molecular Sciences·Gaelle TachonLucie Karayan-Tapon
Sep 28, 2018·The Journal of Biological Chemistry·Priyanka P KakadTanja A Godenschwege
Nov 25, 2018·Journal of Cellular Physiology·Nazi AghaalikhaniMarzieh Mahmoodi
Jan 18, 2020·The Journal of Experimental Medicine·Anders EtzerodtToby Lawrence
Feb 6, 2020·Journal of Clinical Medicine·Elena Laura MazzoldiStefano Indraccolo
Feb 27, 2019·Current Stem Cell Research & Therapy·Eloisi Caldas-LopesMonica L Guzman
Feb 24, 2021·Phytotherapy Research : PTR·Sorayya GhasemiZahra Lorigooini
Mar 6, 2021·Frontiers in Oncology·Plabon Kumar DasAlfred K Lam
May 8, 2021·Cancer Metastasis Reviews·Sugandha Saxena, Rakesh K Singh
Aug 7, 2021·Frontiers in Oncology·Miriam GaggianesiGiorgio Stassi
Apr 17, 2016·Genes & Development·Toni Celià-Terrassa, Yibin Kang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Related Papers

Cellular and Molecular Life Sciences : CMLS
Hong QiuGaoliang Ouyang
International Journal of Cancer. Journal International Du Cancer
Jin HaoZhihe Zhao
Current Medicinal Chemistry
Francesca GullottaAlessandra di Masi
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
Zhiwei WangFazlul H Sarkar
© 2021 Meta ULC. All rights reserved